The new frontier of genome engineering with CRISPR-Cas9
The DOI matches its Crossref record; 153 of the 154 references it cites were found in a registry or an index.
Abstract
The advent of facile genome engineering using the bacterial RNA-guided CRISPR-Cas9 system in animals and plants is transforming biology. We review the history of CRISPR (clustered regularly interspaced palindromic repeat) biology from its initial discovery through the elucidation of the CRISPR-Cas9 enzyme mechanism, which has set the stage for remarkable developments using this technology to modify, regulate, or mark genomic loci in a wide variety of cells and organisms from all three domains of life. These results highlight a new era in which genomic manipulation is no longer a bottleneck to experiments, paving the way toward fundamental discoveries in biology, with applications in all branches of biotechnology, as well as strategies for human therapeutics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Repurposing bacterial “CRISPR” systems to facilitate RNA-guided cleavage of complementary DNA has revolutionized the field of gene editing in mammalian cells 1–4.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [3]
In the citing paper
“The CRISPR/Cas9 genome-editing system provides us an unprecedented opportunity to target and modify genomic sequences with high levels of efficacy and specificity [151,152,153,154,155].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [152]
In the citing paper
“gene-editing techniques such as CRISPR-Cas9 [11], have led to a “democratization” of molecular biology, with functional and genomic analyses now possible in a wide range of species”
From Back to the Basics: Cnidarians Start to Fire (2017) · cites this paper as [11]
In the citing paper
“This outlook has changed dramatically in the last few years due to the introduction of novel methods that can be directly applied to a wide variety of species.”
From Back to the Basics: Cnidarians Start to Fire (2017) · cites this paper as [11]
In the citing paper
“Cas9:sgRNA recognizes the protospacer-adjacent motif (PAM) sequence and a complementary 20-nucleotide genomic sequence and induces double-strand DNA breaks, which are repaired by error-prone nonhomologous end-joining (NHEJ) or precise homology-directed repair (HDR)2,5.”
From Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo (2016) · cites this paper as [2]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationMultiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210 · cited 5×
“Targeting with multiple sgRNAs—referred to as multiplexing—was also successfully achieved (75, 86).”
InfluentialCRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947 · cited 3×
“provided the first experimental evidence of CRISPRCas–mediated adaptive immunity (45).”
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762 · cited 2×
“Manyoftheseapplicationshavebeendiscussedinre-centreviews( 91 – 93 ).”
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234 · cited 1×
“This approach was also used to identify genes essential for cell viability in cancer and pluripotent stem cells (102).”
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016 · cited 1×
“coli, whole-genome sequencing showed that there were no detectable off-target effects (127).”
Self-citationDNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696 · cited 1×
“Specifically, fusion of dCas9 to effector domains including VP64 or KRAB allowed stable and efficient transcriptional activation or repression, respectively, in human and yeast cells (129).”
Self-citationWang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Cited by
Items 501–600 of 1,072
Wimberger, S., Akrap, N., Firth, M. A., Brengdahl, J., Engberg, S., Schwinn, M. K., Slater, M. R., Lundin, A., Hsieh, P.-P., Li, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40344-4 · Cited by 149
Palermo, G., Miao, Y., Walker, R. C., Jinek, M., & McCammon, J. A. (2016) · ACS Central Science · doi:10.1021/acscentsci.6b00218 · Cited by 136
Zhao, X., Liu, L., Lang, J., Cheng, K., Wang, Y., Li, X., Shi, J., Wang, Y., & Nie, G. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.05.042 · Cited by 136
Liang, Y., Liu, Q., Wang, X., Huang, C., Xu, G., Hey, S., Lin, H.-Y., Li, C., Xu, D., Wu, L., et al. (2018) · New Phytologist · doi:10.1111/nph.15512 · Cited by 161
Katayama, T., Nakamura, H., Zhang, Y., Pascal, A., Fujii, W., & Maruyama, J. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.01896-18 · Cited by 144
“various organisms, such as mammalian cells, plants, fish, and yeast (5).”
BackgroundEş, I., Gavahian, M., Marti-Quijal, F. J., Lorenzo, J. M., Mousavi Khaneghah, A., Tsatsanis, C., Kampranis, S. C., & Barba, F. J. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.02.006 · Cited by 128
An Efficient, Rapid, and Recyclable System for CRISPR-Mediated Genome Editing in Candida albicans
Nguyen, N., Quail, M. M. F., & Hernday, A. D. (2017) · mSphere · doi:10.1128/mspheredirect.00149-17 · Cited by 136
Nanozyme's catching up: activity, specificity, reaction conditions and reaction types
Li, Y., & Liu, J. (2020) · Materials Horizons · doi:10.1039/d0mh01393e · Cited by 142
Efficient CRISPR/Cas9-Mediated Genome Editing Using a Chimeric Single-Guide RNA Molecule
Butt, H., Eid, A., Ali, Z., Atia, M. A. M., Mokhtar, M. M., Hassan, N., Lee, C. M., Bao, G., & Mahfouz, M. M. (2017) · Frontiers in Plant Science · doi:10.3389/fpls.2017.01441 · Cited by 130
“The process of NHEJ is predominant in plants, while HR is quite inefficient (Puchta et al., 1996; Symington and Gautier, 2011; Doudna and Charpentier, 2014; Steinert et al., 2016).”
BackgroundOvercoming Self-Incompatibility in Diploid Potato Using CRISPR-Cas9
Enciso-Rodríguez, F. E., Manrique-Carpintero, N. C., Nadakuduti, S. S., Buell, C. R., Zarka, D. G., & Douches, D. S. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00376 · Cited by 148
“The target-DNA recognition is mediated by a single guide RNA (sgRNA) bearing a 20 bp target-site complementary to the region adjacent to a protospacer-adjacent motif (PAM), 5′-NGG-3′, resulting in the generation of a DSB (Doudna and Charpentier, 2014; Sternberg et al., 2014; Pellagatti et al., 2015) which can be lever…”
InfluentialHe, D., Wang, J., Lu, Y., Deng, Y., Zhao, C., Xu, L., Chen, Y., Hu, Y.-C., Zhou, W., & Lu, Q. R. (2017) · Neuron · doi:10.1016/j.neuron.2016.11.044 · Cited by 133
Santos-Carballal, B., Fernández, E. F., & Goycoolea, F. M. (2018) · Polymers · doi:10.3390/polym10040444 · Cited by 142
“Indeed, an ongoing revolution in the therapeutic paradigms for many diseases, particularly genetic diseases, is currently underway, and we have only started to see the “tip of the iceberg” [6].”
BackgroundThe History of Colistin Resistance Mechanisms in Bacteria: Progress and Challenges
Hamel, M., Rolain, J., & Baron, S. A. (2021) · Microorganisms · doi:10.3390/microorganisms9020442 · Cited by 148
“The gRNA targeting specific sequences recruits the Cas9 protein to form the compound, and the Cas9 protein acts as a nuclease and generates a blunt end double-strand break [99].”
BackgroundA user’s guide to golden gate cloning methods and standards
Bird, J. E., Marles-Wright, J., & Giachino, A. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00355 · Cited by 135
Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD
Bui, H. M., Enis, D. R., Robciuc, M. R., Nurmi, H. J., Cohen, J. D., Chen, M., Yang, Y., Dhillon, V., Johnson, K., Zhang, H., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83967 · Cited by 135
“CRISPR-Cas9 genome editing is highly efficient but may also result in off-target mutations (31).”
BackgroundHighly specific targeted mutagenesis in plants using Staphylococcus aureus Cas9
Kaya, H., Mikami, M., Endo, A., Endo, M., & Toki, S. (2016) · Scientific Reports · doi:10.1038/srep26871 · Cited by 132
Gene editing for cell engineering: trends and applications
Gupta, S. K., & Shukla, P. (2017) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2016.1214557 · Cited by 127
“This is then further processed into small Cr-RNA and Trans-activating Cr-RNA.[1,2] The Cas9 protein associated with Crispr has two domains RuvC and HNH which are the cleavage domains for Cas9 system.”
BackgroundInfluentialMeyer, C., Garzia, A., Mazzola, M., Gerstberger, S., Molina, H., & Tuschl, T. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.011 · Cited by 127
“In order to characterize essential RBPs, we combined the CRISPR-Cas9 knockout technology (Doudna and Charpentier, 2014) with Dox-inducible complementation of the knockout gene.”
CRISPR/Cas9‐mediated genome editing: From basic research to translational medicine
Jacinto, F. V., Link, W., & Ferreira, B. I. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14916 · Cited by 148
Hunt, J., Samson, C., du Rand, A., & Sheppard, H. M. (2023) · Human Genetics · doi:10.1007/s00439-023-02561-1 · Cited by 151
“Using this approach, gene-editing is typically facilitated by the CRISPR-associated protein 9 (Cas9), an endonuclease which cleaves double-stranded DNA at genomic loci defined by a 20-nucleotide guide RNA (gRNA) and a three-nucleotide protospacer adjacent motif (PAM) (Doudna and Charpentier 2014).”
MethodGeneration and validation of homozygous fluorescent knock-in cells using CRISPR-Cas9 genome editing
Koch, B., Nijmeijer, B., Kueblbeck, M., Cai, Y., Walther, N., & Ellenberg, J. (2018) · Nature Protocols · doi:10.1038/nprot.2018.042 · Cited by 134
Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex
Saayman, S. M., Lazar, D. C., Scott, T. A., Hart, J. R., Takahashi, M., Burnett, J. C., Planelles, V., Morris, K. V., & Weinberg, M. S. (2016) · Molecular Therapy · doi:10.1038/mt.2015.202 · Cited by 131
Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage
Kulcsár, P. I., Tálas, A., Huszár, K., Ligeti, Z., Tóth, E., Weinhardt, N., Fodor, E., & Welker, E. (2017) · Genome Biology · doi:10.1186/s13059-017-1318-8 · Cited by 130
Modrzejewski, D., Hartung, F., Sprink, T., Krause, D., Kohl, C., & Wilhelm, R. (2019) · Environmental Evidence · doi:10.1186/s13750-019-0171-5 · Cited by 120
CRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations
Memi, F., Ntokou, A., & Papangeli, I. (2018) · Seminars in Perinatology · doi:10.1053/j.semperi.2018.09.003 · Cited by 157
Lyu, Y., He, S., Li, J., Jiang, Y., Sun, H., Miao, Y., & Pu, K. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201909264 · Cited by 134
Applications of biosensors in Alzheimer's disease diagnosis
Brazaca, L. C., Sampaio, I., Zucolotto, V., & Janegitz, B. C. (2020) · Talanta · doi:10.1016/j.talanta.2019.120644 · Cited by 133
How to turn an organism into a model organism in 10 ‘easy’ steps
Matthews, B. J., & Vosshall, L. B. (2020) · Journal of Experimental Biology · doi:10.1242/jeb.218198 · Cited by 136
“The bacterial type II-A CRISPR-Cas9 system from Streptococcus pyogenes was the first to be adapted as a flexible genome-editing tool and remains the most commonly used system to date (Doudna and Charpentier, 2014).”
BackgroundAccessing Legacy Phosphorus in Soils
Doydora, S. A., Gatiboni, L. C., Grieger, K., Hesterberg, D. L., Jones, J. L., McLamore, E. S., Peters, R. A., Sozzani, R., den Broeck, L. V., & Duckworth, O. W. (2020) · Soil Systems · doi:10.3390/soilsystems4040074 · Cited by 146
“It would be foreseeable to use genome editing technologies, such as CRISPR (clustered regularly interspaced short palindromic repeats) technologies [142,143], to genetically test the functional relevance of known (e.”
Evolutionary Parasitology: The Integrated Study of Infections, Immunology, Ecology, and Genetics
Schmid‐Hempel, P. (2021) · doi:10.1093/oso/9780198832140.001.0001 · Cited by 166
In Silico Meets In Vivo : Towards Computational CRISPR-Based sgRNA Design
Chuai, G., Wang, Q., & Liu, Q. (2016) · Trends in biotechnology · doi:10.1016/j.tibtech.2016.06.008 · Cited by 143
Barriers for HIV Cure: The Latent Reservoir
Castro‐Gonzalez, S., Colomer-Lluch, M., & Serra-Moreno, R. (2018) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2018.0118 · Cited by 158
“Genetic modulation by CRISPR/Cas9 is based on the use of a guide RNA (gRNA) that recognizes and mutates target DNA in the HIV-1 genome, offering sequence-dependent specificity and high cleavage efficiency.(249,250) These properties make CRISPR/Cas9 a very attractive tool to permanently inactivate or even remove the pr…”
BackgroundNanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics
Givens, B. E., Naguib, Y. W., Geary, S. M., Devor, E. J., & Salem, A. K. (2018) · The AAPS Journal · doi:10.1208/s12248-018-0267-9 · Cited by 145
“Also, unlike RNA interference (RNAi) techniques, CRISPR/Cas9 therapy is potentially a one-time treatment with lasting effects since the target is DNA as opposed to RNA (10,15).”
Extrachromosomal circular DNA: biogenesis, structure, functions and diseases
Yang, L., Jia, R., Ge, T., Ge, S., Zhuang, A., Chai, P., & Fan, X. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01176-8 · Cited by 156
Weninger, A., Fischer, J. E., Raschmanová, H., Kniely, C., Vogl, T., & Glieder, A. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26474 · Cited by 139
Kumar, R., Le, N., Tan, Z., Brown, M. E., Jiang, S., & Reineke, T. M. (2020) · ACS Nano · doi:10.1021/acsnano.0c08549 · Cited by 142
Self‐Assembled DNA Nanoclews for the Efficient Delivery of CRISPR–Cas9 for Genome Editing
Sun, W., Ji, W., Hall, J. M., Hu, Q., Wang, C., Beisel, C. L., & Gu, Z. (2015) · Angewandte Chemie · doi:10.1002/ange.201506030 · Cited by 130
Expanding the genetic toolkit in Xenopus: Approaches and opportunities for human disease modeling
Tandon, P., Conlon, F. L., Furlow, J. D., & Horb, M. E. (2016) · Developmental Biology · doi:10.1016/j.ydbio.2016.04.009 · Cited by 144
“Researchers have exploited the programmable nature of this DNA targeting nuclease to mutate specific genetic loci of interest in many model systems including Xenopus (Blitz et al., 2013; Cho et al., 2013; Cong et al., 2013; Doudna and Charpentier, 2014; Guo et al., 2014; Harrison et al., 2014; Jinek et al., 2012; Mali…”
BackgroundPathways to de‐extinction: how close can we get to resurrection of an extinct species?
Shapiro, B. (2017) · Functional Ecology · doi:10.1111/1365-2435.12705 · Cited by 121
“The third approach to resurrecting extinct species takes advantage of recent advances in two fields, ancient DNA and genome editing (Doudna & Charpentier 2014; Shapiro & Hofreiter 2014), which together pave what I believe is the most likely route to de-extinction (Shapiro 2015).”
BackgroundInflation with Covid Consumption Baskets
Cavallo, A. F. (2020) · National Bureau of Economic Research · doi:10.3386/w27352 · Cited by 131
Multiplexed Gene Editing and Protein Overexpression Using a Tobacco mosaic virus Viral Vector
Cody, W. B., Scholthof, H. B., & Mirkov, T. E. (2017) · Plant Physiology · doi:10.1104/pp.17.00411 · Cited by 129
“Recently, the Streptococcus pyogenes CRISPR/Cas9 system has been adapted as a programmable DNA targeting RNA-guided nuclease complex for gene editing (Doudna and Charpentier, 2014).”
BackgroundDevelopment of hRad51–Cas9 nickase fusions that mediate HDR without double-stranded breaks
Rees, H. A., Yeh, W.-H., & Liu, D. R. (2019) · Nature Communications · doi:10.1038/s41467-019-09983-4 · Cited by 120
mRNA Delivery by a pH‐Responsive DNA Nano‐Hydrogel
Fu, X., Chen, T., Song, Y., Feng, C., Chen, H., Zhang, Q., Chen, G., & Zhu, X. (2021) · Small · doi:10.1002/smll.202101224 · Cited by 133
Biotechnological Advances to Improve Abiotic Stress Tolerance in Crops
Villalobos-López, M. Á., Arroyo-Becerra, A., Quintero-Jiménez, A., & Iturriaga, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231912053 · Cited by 150
Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes
Ma, E., Harrington, L. B., O’Connell, M. R., Zhou, K., & Doudna, J. A. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.030 · Cited by 125
“398 Molecular Cell 60, 398–407, November 5, 2015 a2015 Elsevier In NGG PAM sequence (Doudna and Charpentier, 2014; Sontheimer and Barrangou, 2015; Terns and Terns, 2014).”
InfluentialSelf-citationWang, L., Wang, L., Tan, Q., Fan, Q., Zhu, H., Hong, Z., Zhang, Z., & Duanmu, D. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.01333 · Cited by 126
“DNA Extraction, PCR/RE Assay, and Sequencing Genomic DNA was extracted using a method described by Li et al. (2010). PCR amplification was performed using gene specific primers under the conditions mentioned above.”
MethodEthical issues of CRISPR technology and gene editing through the lens of solidarity
Mulvihill, J. J., Capps, B., Joly, Y., Lysaght, T., Zwart, H. A. E., & CHADWICK, R. F. (2017) · British Medical Bulletin · doi:10.1093/bmb/ldx002 · Cited by 131
Gene Therapy with the Sleeping Beauty Transposon System
Kebriaei, P., Izsvák, Z., Narayanavari, S. A., Singh, H., & Ivics, Z. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.08.008 · Cited by 142
Li, M., Xie, H., Liu, Y., Xia, C., Cun, X., Long, Y., Chen, X., Deng, M., Guo, R., Zhang, Z., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.05.019 · Cited by 129
Fourth generation biofuel from genetically modified algal biomass: Challenges and future directions.
Shokravi, H., Shokravi, Z., Heidarrezaei, M., Ong, H. C., Rahimian Koloor, S. S., Petrů, M., Lau, W. J., & Ismail, A. F. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.131535 · Cited by 127
Molecular breakthroughs in modern plant breeding techniques
Aziz, M. A., & Masmoudi, K. (2024) · Horticultural Plant Journal · doi:10.1016/j.hpj.2024.01.004 · Cited by 146
Synthetic approaches to protein phosphorylation
Chen, Z., & Cole, P. A. (2015) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2015.07.001 · Cited by 123
“Furthermore, using the newer CrispR/Cas9-related technologies, germline editing of the genome is becoming straightforward so a ‘knock-in’ point mutation of a phosphorylation site can be efficiently prepared and analyzed in vivo [25].”
MethodPrecise Editing at DNA Replication Forks Enables Multiplex Genome Engineering in Eukaryotes
Barbieri, E. M., Muir, P., Akhuetie‐Oni, B. O., Yellman, C. M., & Isaacs, F. J. (2017) · Cell · doi:10.1016/j.cell.2017.10.034 · Cited by 131
Engineering cell signaling using tunable CRISPR–Cpf1-based transcription factors
Liu, Y., Han, J., Chen, Z., Wu, H., Dong, H., & Nie, G. (2017) · Nature Communications · doi:10.1038/s41467-017-02265-x · Cited by 132
Sturluson, Á., Huynh, M. T., Kaija, A. R., Laird, C., Yoon, S., Hou, F., Feng, Z., Wilmer, C. E., Colón, Y. J., Chung, Y. G., et al. (2019) · Molecular Simulation · doi:10.1080/08927022.2019.1648809 · Cited by 130
“A lesson from molecular biology CRISPR-Cas9 technology [116] is revolutionising molecular biology by enabling the facile, precise, and cost-effective editing of genomes [116].”
BackgroundBase editing in plants: Current status and challenges
Bharat, S. S., Li, S., Li, J., Yan, L., & Xia, L. (2019) · The Crop Journal · doi:10.1016/j.cj.2019.10.002 · Cited by 135
Gramene 2021: harnessing the power of comparative genomics and pathways for plant research
Tello-Ruiz, M. K., Naithani, S., Gupta, P., Olson, A., Wei, S., Preece, J., Jiao, Y., Wang, B., Chougule, K., Garg, P., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa979 · Cited by 120
Bhat, M. A., Mir, R. A., Kumar, V., Shah, A. A., Zargar, S. M., Rahman, S., & Jan, A. T. (2021) · Physiologia Plantarum · doi:10.1111/ppl.13359 · Cited by 128
Adeno-associated Virus Vectors in Gene Therapy
Mary, B., Khan, N., Arumugam, S., Saxena, H., Kumar, M., Manimaran, P., Chattopadhyay, S., & Jayandharan, G. R. (2018) · Springer eBooks · doi:10.1007/978-981-13-0481-1_2 · Cited by 127
Biomedical applications of mRNA nanomedicine
Xiong, Q., Lee, G. Y., Ding, J., Li, W., & Shi, J. (2018) · Nano Research · doi:10.1007/s12274-018-2146-1 · Cited by 125
Fenini, G., Grossi, S., Contassot, E., Biedermann, T., Reichmann, E., French, L. E., & Beer, H.-D. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.07.016 · Cited by 125
“However, genome editing via the CRISPR/Cas9 approach would allow a more specific genetic modification of keratinocytes and, in principle, gene therapy for other genetic diseases affecting keratinocytes of the epidermis (Doudna and Charpentier, 2014; Zhang et al., 2014).”
BackgroundCercospora beticola: The intoxicating lifestyle of the leaf spot pathogen of sugar beet
Rangel, L. I., Spanner, R., Ebert, M. K., Pethybridge, S. J., Stukenbrock, E. H., de Jonge, R., Secor, G. A., & Bolton, M. D. (2020) · Molecular Plant Pathology · doi:10.1111/mpp.12962 · Cited by 136
“Schuster, M. and Kahmann, R. (2019) CRISPR-Cas9 genome editing approaches in filamentous fungi and oomycetes.”
InfluentialSong, C.-Q., Li, Y., Mou, H., Moore, J., Park, A., Pomyen, Y., Hough, S., Kennedy, Z., Fischer, A., Yin, H., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.12.002 · Cited by 121
Identifying and characterizing SCRaMbLEd synthetic yeast using ReSCuES
Luo, Z., Wang, L., Wang, Y., Zhang, W., Guo, Y., Shen, Y., Jiang, L., Wu, Q., Zhang, C., Cai, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-00806-y · Cited by 138
Machine learning predicts new anti-CRISPR proteins
Eitzinger, S., Asif, A., Watters, K. E., Iavarone, A. T., Knott, G. J., Doudna, J. A., & Minhas, F. U. A. A. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa219 · Cited by 121
“Due to their high degree of sequence specificity, CRISPR–Cas systems have been adapted for use as programmable DNA or RNA editing tools with novel applications in biotechnology, diagnostics, medicine, agriculture, and more (5–9).”
Self-citationRen, Y., Li, M., Guo, S., Sun, H., Zhao, J., Zhang, J., Liu, G., He, H., Tian, S., Yu, Y., et al. (2021) · The Plant Cell · doi:10.1093/plcell/koab055 · Cited by 124
A review of recent advances in fungal mycelium based composites
Madusanka, C., Udayanga, D., Nilmini, R., Rajapaksha, S. M., Hewawasam, C., Manamgoda, D. S., & Vasco‐Correa, J. (2024) · Discover Materials · doi:10.1007/s43939-024-00084-8 · Cited by 138
“Therefore, it is more accurate, cheaper, faster, and more efficient than other genome editing approaches [88].”
Palermo, G., Chen, J. S., Ricci, C. G., Rivalta, I., Jinek, M., Batista, V. S., Doudna, J. A., & McCammon, J. A. (2018) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583518000070 · Cited by 123
“CRISPR (clustered regularly interspaced short palindromic repeat)–Cas9 is a bacterial adaptive immune system, which has revolutionized life sciences through the introduction of a facile genome editing technology (Doudna and Charpentier, 2014; Jinek et al., 2012).”
BackgroundSelf-citationIn utero gene editing for monogenic lung disease
Alapati, D., Zacharias, W. J., Hartman, H. A., Rossidis, A. C., Stratigis, J. D., Ahn, N. J., Coons, B., Zhou, S., Li, H., Singh, K., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav8375 · Cited by 123
Genome Engineering Using Adeno-associated Virus: Basic and Clinical Research Applications
Gaj, T., Epstein, B. E., & Schaffer, D. V. (2016) · Molecular Therapy · doi:10.1038/mt.2015.151 · Cited by 119
Targeted mutagenesis in a human-parasitic nematode
Gang, S. S., Castelletto, M. L., Bryant, A. S., Yang, E. C., Mancuso, N., Lopez, J. B., Pellegrini, M. A., & Hallem, E. A. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006675 · Cited by 131
“CRISPR-Cas9-induced DSBs can also be resolved by HDR when a repair template is provided [5].”
InfluentialDevelopment of CRISPR/Cas9 system in Chlorella vulgaris FSP-E to enhance lipid accumulation
Lin, W.-R., & Ng, I.-S. (2020) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2019.109458 · Cited by 121
Allosteric Motions of the CRISPR–Cas9 HNH Nuclease Probed by NMR and Molecular Dynamics
East, K. W., Newton, J. C., Morzan, U. N., Narkhede, Y. B., Acharya, A., Skeens, E., Jogl, G., Batista, V. S., Palermo, G., & Lisi, G. P. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b10521 · Cited by 124
Elevating seed oil content in a polyploid crop by induced mutations in SEED FATTY ACID REDUCER genes
Karunarathna, N. L., Wang, H., Harloff, H., Jiang, L., & Jung, C. (2020) · Plant Biotechnology Journal · doi:10.1111/pbi.13381 · Cited by 119
“In the case of rapeseed, the CRISPR-Cas technology proved to be a powerful tool (Doudna and Charpentier, 2014) to create multiple mutations within gene families (Braatz et al. , 2017).”
Cleves, P. A., Tinoco, A. I., Bradford, J., Perrin, D., Bay, L. K., & Pringle, J. R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920779117 · Cited by 134
Wood Derived Cellulose Scaffolds—Processing and Mechanics
Keplinger, T., Wittel, F. K., Rüggeberg, M., & Burgert, I. (2020) · Advanced Materials · doi:10.1002/adma.202001375 · Cited by 126
Genetic alphabet expansion technology by creating unnatural base pairs
Kimoto, M., & Hirao, I. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00457j · Cited by 129
PE-Designer and PE-Analyzer: web-based design and analysis tools for CRISPR prime editing
Hwang, G.-H., Jeong, Y. K., Habib, O., Hong, S.-A., Lim, K., Kim, J.-S., & Bae, S. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab319 · Cited by 117
Sugano, S. S., Suzuki, H., Shimokita, E., Chiba, H., Noji, S., Osakabe, Y., & Osakabe, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-00883-5 · Cited by 127
Cromer, M. K., Vaidyanathan, S., Ryan, D. E., Curry, B., Lucas, A. B., Camarena, J., Kaushik, M., Hay, S. R., Martin, R. M., Steinfeld, I., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.06.002 · Cited by 120
Genome editing for plant research and crop improvement
Zhan, X., Lu, Y., Zhu, J., & Botella, J. R. (2021) · Journal of Integrative Plant Biology · doi:10.1111/jipb.13063 · Cited by 126
Haghighi, E., Abolmaali, S. S., Dehshahri, A., Shaegh, S. A. M., Azarpira, N., & Tamaddon, A. M. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02972-w · Cited by 130
Cancer research using organoid technology
Kretzschmar, K. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01990-z · Cited by 120
Diversity of CRISPR-Cas immune systems and molecular machines
Barrangou, R. (2015) · Genome biology · doi:10.1186/s13059-015-0816-9 · Cited by 133
Engineering Delivery Vehicles for Genome Editing
Nelson, C. E., & Gersbach, C. A. (2016) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-080615-034711 · Cited by 118
Nucleosomes Inhibit Cas9 Endonuclease Activity in Vitro
Hinz, J. M., Laughery, M. F., & Wyrick, J. J. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b01108 · Cited by 111
Micro-/nanoscale electroporation
Chang, L., Li, L., Shi, J., Sheng, Y., Lu, W., Gallego‐Perez, D., & Lee, L. J. (2016) · Lab on a Chip · doi:10.1039/c6lc00840b · Cited by 125
The genetics of depression: successful genome-wide association studies introduce new challenges
Ormel, J., Hartman, C. A., & Snieder, H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0450-5 · Cited by 111
Emerging genetic therapy for sickle cell disease
Orkin, S. H., & Bauer, D. E. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-041817-125507 · Cited by 119
Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection
Huang, C., Lee, K.-C., & Doudna, J. A. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.05.006 · Cited by 128
Self-citationWan, T., Niu, D., Wu, C., Xu, F.-J., Church, G., & Ping, Y. (2019) · Materials Today · doi:10.1016/j.mattod.2018.12.003 · Cited by 117
Precision Control of CRISPR-Cas9 Using Small Molecules and Light
Gangopadhyay, S. A., Cox, K. J., Manna, D., Lim, D., Maji, B., Zhou, Q., & Choudhary, A. (2019) · Biochemistry · doi:10.1021/acs.biochem.8b01202 · Cited by 123
Programmable Extracellular Vesicles for Macromolecule Delivery and Genome Modifications
Zhang, X., Xu, Q., Zi, Z., Liu, Z., Wan, C., Crisman, L., Shen, J., & Liu, X. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.11.007 · Cited by 111
A chemical approach for global protein knockdown from mice to non-human primates
Sun, X., Wang, J., Yao, X., Zheng, W., Mao, Y., Lan, T., Wang, L., Sun, Y., Zhang, X., Zhao, Q., et al. (2019) · Cell Discovery · doi:10.1038/s41421-018-0079-1 · Cited by 118
Zhong, C., Yin, Q., Xie, Z., Bai, M., Dong, R., Tang, W., Xing, Y., Zhang, H., Yang, S., Chen, L., et al. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.06.005 · Cited by 118
“This system, consisting of the Cas9 nuclease and a single-guide RNA (sgRNA) targeting a specific gene, is relatively easy to implement compared to other gene-editing techniques (Doudna and Charpentier, 2014).”
MethodGenome Editing: A New Approach to Human Therapeutics
Porteus, M. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124454 · Cited by 114
Metabolic Engineering of Probiotic Saccharomyces boulardii
Liu, J., Kong, I. I., Zhang, G.-C., Jayakody, L. N., Kim, H., Xia, P., Kwak, S., Sung, B. H., Sohn, J., Walukiewicz, H. E., et al. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.00057-16 · Cited by 126
“The clustered regularly interspaced short palindromic repeat (CRISPR)-Cas9 system (20, 21) is an emerging and powerful genomic engineering tool that has been widely used in bacteria (22), yeast (23), and mammalian cells (24).”
BackgroundModifying the Mitochondrial Genome
Patananan, A. N., Wu, T.-H., Chiou, P.-Y., & Teitell, M. A. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.04.004 · Cited by 117
“However, it is unclear whether CRISPR-Cas9 could cleave or edit mtDNAs because it is challenging to import the guide RNA component into mitochondria (Doudna and Charpentier, 2014; Hashimoto et al., 2015; Liang et al., 2015).”
Genome editing by natural and engineered CRISPR-associated nucleases
Wu, W. Y., Lebbink, J. H. G., Kanaar, R., Geijsen, N., & John van der, O. O. S. T. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0080-x · Cited by 125
BioBits™ Bright: A fluorescent synthetic biology education kit
Stark, J. C., Huang, A., Nguyen, P. Q., Dubner, R. S., Hsu, K. J., Ferrante, T. C., Anderson, M. E., Kanapskyte, A., Mucha, Q., Packett, J. S., et al. (2018) · Science Advances · doi:10.1126/sciadv.aat5107 · Cited by 120
Metadata
- Authors
- Doudna, J. A., & Charpentier, E.
- Affiliations
- Howard Hughes Medical Institute (US)
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Doudna, Jennifer A.
- Charpentier, Emmanuelle
- Venue
- Science
- Published
- 2014-11-28
- Volume
- 346
- Issue
- 6213
- Pages
- 1258096-1258096
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2050480410
- Semantic Scholar
- e138728065ae7707ff75c3b6a5a52e81856ccf1b
- Cited by
- 7,062
- References
- 154
- Citations by year
- 2026: 560 · 2025: 716 · 2024: 665 · 2023: 580 · 2022: 689 · 2021: 700 · 2020: 653 · 2019: 578 · 2018: 569 · 2017: 545 · 2016: 471 · 2015: 314 · 2014: 3
- FWCI
- 41.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR/Cas9, genome editing, RNA-guided genome editing, genome modification, genome regulation, biotechnology applications, human therapeutics
- MeSH terms
- Animals, Genetic Engineering, Humans, Genome, Human, Gene Targeting, DNA Cleavage, RNA, Small Untranslated, Clustered Regularly Interspaced Short Palindromic Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.